{
    "startDate": "2021-01-01",
    "endDate": "2021-03-31",
    "year": "2021",
    "quarter": "Q1",
    "symbol": "IONS",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 414155000
            },
            {
                "label": "Short-term investments",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 1405840000
            },
            {
                "label": "Contracts receivable",
                "concept": "ContractWithCustomerAssetNetCurrent",
                "unit": "usd",
                "value": 23397000
            },
            {
                "label": "Inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 22199000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 123827000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1989418000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 180413000
            },
            {
                "label": "Patents, net",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 28795000
            },
            {
                "label": "Deposits and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 49925000
            },
            {
                "label": "Amortization of patents",
                "concept": "Assets",
                "unit": "usd",
                "value": 2248551000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 9506000
            },
            {
                "label": "Accrued compensation",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 29263000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 78766000
            },
            {
                "label": "Income taxes payable",
                "concept": "AccruedIncomeTaxesCurrent",
                "unit": "usd",
                "value": 1326000
            },
            {
                "label": "Current portion of 1 percent convertible senior notes, net",
                "concept": "ConvertibleDebtCurrent",
                "unit": "usd",
                "value": 61816000
            },
            {
                "label": "Current portion of deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 106740000
            },
            {
                "label": "Accrued liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 295105000
            },
            {
                "label": "Long-term deferred contract revenue",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 401966000
            },
            {
                "label": "Long-term mortgage debt",
                "concept": "LongTermLoansFromBank",
                "unit": "usd",
                "value": 60002000
            },
            {
                "label": "Accrued liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1567987000
            },
            {
                "label": "Common stock, $0.001 par value; 300,000,000 shares authorized, 140,924,356 and 140,365,594 shares issued and outstanding at March 31, 2021 (unaudited) and December 31, 2020, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 141000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 1925801000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -24203000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1221175000
            },
            {
                "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 680564000
            },
            {
                "label": "Total liabilities and stockholders' equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 2248551000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -89869000
            },
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 3917000
            },
            {
                "label": "Amortization of right-of-use operating lease assets",
                "concept": "OperatingLeaseRightOfUseAssetAmortizationExpense",
                "unit": "usd",
                "value": 394000
            },
            {
                "label": "Amortization of patents",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 544000
            },
            {
                "label": "Amortization of premium (discount) on investments, net",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -4023000
            },
            {
                "label": "Amortization of debt issuance costs",
                "concept": "AmortizationOfFinancingCosts",
                "unit": "usd",
                "value": 860000
            },
            {
                "label": "Payments of tax withholdings related to vesting of employee stock awards and exercise of employee stock options",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 37861000
            },
            {
                "label": "Gain on investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": 13000
            },
            {
                "label": "Non-cash losses related to patents",
                "concept": "ImpairmentOfIntangibleAssetsFinitelived",
                "unit": "usd",
                "value": 221000
            },
            {
                "label": "Provision for deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Contracts receivable",
                "concept": "IncreaseDecreaseInContractWithCustomerAsset",
                "unit": "usd",
                "value": -52807000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 234000
            },
            {
                "label": "Other current and long-term assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -16481000
            },
            {
                "label": "Income taxes payable",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -9569000
            },
            {
                "label": "Accrued compensation",
                "concept": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -36465000
            },
            {
                "label": "Accrued liabilities and other current liabilities",
                "concept": "IncreaseDecreaseInOtherCurrentLiabilities",
                "unit": "usd",
                "value": -11905000
            },
            {
                "label": "Deferred contract revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": -23717000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -54662000
            },
            {
                "label": "Purchases of short-term investments",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 330051000
            },
            {
                "label": "Proceeds from sale of short-term investments",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 411907000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 1772000
            },
            {
                "label": "Acquisition of licenses and other assets, net",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 1228000
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 78856000
            },
            {
                "label": "Proceeds from equity, net",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
                "unit": "usd",
                "value": 7760000
            },
            {
                "label": "Payments of tax withholdings related to vesting of employee stock awards and exercise of employee stock options",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 15337000
            },
            {
                "label": "Repurchases and retirements of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -7577000
            },
            {
                "label": "Effects of exchange rates on cash",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -126000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 16491000
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 594000
            },
            {
                "label": "Income taxes paid",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 2000
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 111607000
            },
            {
                "label": "Cost of sales",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 2578000
            },
            {
                "label": "Selling, General and Administrative Expense [Member]",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 61199000
            },
            {
                "label": "Expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 203578000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -91971000
            },
            {
                "label": "Investment income",
                "concept": "InvestmentIncomeNet",
                "unit": "usd",
                "value": 4643000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 2414000
            },
            {
                "label": "Other income (expenses)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 3000
            },
            {
                "label": "Loss before income tax (expense) benefit",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -89739000
            },
            {
                "label": "Provision for deferred income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 130000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -89869000
            },
            {
                "label": "Net loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Adjustments to reconcile net loss to net cash used in operating activities:",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -89869000
            },
            {
                "label": "Basic net loss per share (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.64
            },
            {
                "label": "Diluted net loss per share (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Shares used in computing basic net loss per share (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 140770000
            },
            {
                "label": "Shares used in computing diluted net loss per share (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Unrealized losses on debt securities, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -3006000
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -126000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -93001000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interest in Akcea Therapeutics, Inc.",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Comprehensive loss attributable to Ionis Pharmaceuticals, Inc. common stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -93001000
            }
        ]
    }
}